Jefferies analyst Brian Tanquilut maintained a Hold rating on Walgreens Boots Alliance (WBA – Research Report) yesterday and set a price target of $40.00. The company’s shares closed last Friday at $37.86, close to its 52-week low of $37.71.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 3.3% and a 52.2% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Privia Health Group, Quest Diagnostics, and Tenet Healthcare.
Walgreens Boots Alliance has an analyst consensus of Hold, with a price target consensus of $46.00, representing a 22.2% upside. In a report issued on June 17, Deutsche Bank also maintained a Hold rating on the stock with a $46.00 price target.
Walgreens Boots Alliance’s market cap is currently $32.74B and has a P/E ratio of 5.23.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Retail pharmacy leader Walgreens Boots Alliance (NASDAQ:WBA) operates through its namesake brand Walgreens in the U.S. and Boots in the U.K. In addition, it owns retail and business brands including the No7 Beauty Company, Duane Reade, Ahumada in Chile, and Benavides in Mexico. The company also targets equity investments in healthcare, pharmacy, and retail and has a presence in over 25 countries with more than 450,000 employees.
Read More on WBA: